These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6376650)
41. Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization. Sinha VB; Srivastava BS Bull World Health Organ; 1979; 57(4):643-7. PubMed ID: 316741 [TBL] [Abstract][Full Text] [Related]
42. Cholera and other vibrio-associated diarrhoeas. WHO Scientific Working Group Bull World Health Organ; 1980; 58(3):353-74. PubMed ID: 6968251 [TBL] [Abstract][Full Text] [Related]
43. Cholera: recent updates. Weil AA; Ryan ET Curr Opin Infect Dis; 2018 Oct; 31(5):455-461. PubMed ID: 30048254 [TBL] [Abstract][Full Text] [Related]
44. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity. Vakili A; Mousavi Gargari SL; Nazarian S; Amani J Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696 [TBL] [Abstract][Full Text] [Related]
45. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451 [TBL] [Abstract][Full Text] [Related]
46. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae. O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048 [TBL] [Abstract][Full Text] [Related]
47. [Molecular genetic features of Vibrio cholerae classica strains, that caused the Asiatic cholera epidemic in Russian in 1942]. Smirnova NI; Cheldyshova NB; Zadnova SP; Kutyrev VV Mol Gen Mikrobiol Virusol; 2001; (4):12-8. PubMed ID: 11816113 [TBL] [Abstract][Full Text] [Related]
48. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509 [TBL] [Abstract][Full Text] [Related]
50. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins. Satchell KJ Microbes Infect; 2003 Nov; 5(13):1241-7. PubMed ID: 14623020 [TBL] [Abstract][Full Text] [Related]
51. Summary of the 29th United States-Japan joint Conference on Cholera and Related Diarrheal Diseases. Lang DR; Guerrant RL J Infect Dis; 1995 Jan; 171(1):8-12. PubMed ID: 7798685 [No Abstract] [Full Text] [Related]
52. Vaccine development for the control of cholera and related toxin-induced diarrhoeal diseases. Holmgren J; Svennerholm AM Ciba Found Symp; 1985; 112():242-70. PubMed ID: 3891255 [TBL] [Abstract][Full Text] [Related]
53. Cloned cholera enterotoxin genes in study and prevention of cholera. Kaper JB; Levine MM Lancet; 1981 Nov; 2(8256):1162-3. PubMed ID: 6118594 [No Abstract] [Full Text] [Related]
54. Animal models for immunoglobulin A secretion. Keren DF; Suckow MA Methods Enzymol; 1994; 235():140-55. PubMed ID: 8057892 [No Abstract] [Full Text] [Related]
59. Vasoactive drugs on intestinal fluid secretion induced by Vibrio cholera toxin. Strombeck DR Life Sci I; 1971 Dec; 10(24):1403-7. PubMed ID: 5146323 [No Abstract] [Full Text] [Related]
60. On the possible role of intestinal hormones as the diarrhoeagenic messenger in cholera. Osaka M; Fujita T; Yanatori Y Virchows Arch B Cell Pathol; 1975 Sep; 18(4):287-96. PubMed ID: 809916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]